Immunity to experimental fowl typhoid in chickens induced by a virulence plasmid-cured derivative of Salmonella gallinarum.
Chickens were immunized by two intramuscular inoculations at 1 and 14 days of age with virulence plasmid-cured derivatives of Salmonella gallinarum and were challenged 14 days later by oral inoculation of ca. 50 50% lethal doses (LD50) of fully virulent S. gallinarum 9. Mortality in the nonimmunized and immunized groups were 36 and 3%, respectively. This difference was highly significant (P less than 0.01). A significant reduction in mortality was also produced following oral challenge with 5,000 LD50 doses. The LD50 values by intramuscular inoculation of the challenge organism into nonimmunized and immunized chickens were log10 (0.13 +/- 1.57) and (9.74 +/- 2.72), respectively. Immunization was effective whether chickens were immunized at 1 and 14 days of age or at 21 and 35 days of age. Serum agglutinins were present in immunized chickens. Immunization with plasmid-cured Salmonella pullorum gave less protection, and immunization with Escherichia coli K-12 possessing the virulence plasmid of S. gallinarum gave none. The plasmid-cured S. gallinarum was made both rough by virulent bacteriophage activity and nalidixic acid resistant (Nalr) to produce a strain designated 9VP-phi rNalr. It was compared with a Nalr mutant of the rough 9R vaccine strain designated 9 Nalr for virulence and immunogenicity. 9VP-phi rNalr was slightly less protective and less virulent than was the 9R vaccine strain.
AFRC Institute for Animal Health, Houghton Laboratory, Huntingdon, Cambridgeshire, United Kingdom.
P A
PA
Barrow
D000284:Administration, Oral; D000818:Animals; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology*; D002645:Chickens / Q000276:immunology*; D015169:Colony Count, Microbial; D004926:Escherichia coli / Q000276:immunology; D007273:Injections, Intramuscular; D009154:Mutation; D010957:Plasmids; D011201:Poultry Diseases / Q000517:prevention & control*; D012475:Salmonella / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D012481:Salmonella Infections, Animal / Q000517:prevention & control*; D013154:Spleen / Q000382:microbiology; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology; D014774:Virulence / Q000235:genetics
D001428:Bacterial Vaccines; D014613:Vaccines, Attenuated